Clinical Trial Update: Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating DZ-002, a heptamine carboxymethine dye conjugate, as maintenance therapy for metastatic pancreatic cancer is currently enrol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• DZ-002

Snippet

Sponsor: Hoag Memorial Hospital Presbyterian | Conditions: Metastatic Pancreatic Adenocarcinoma, Pancreatic Cancer | Phase 2 | Status: ENROLLING_BY_INVITATION